Aperio Group’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $9.1M | Sell |
52,027
-159
| -0.3% | -$27.5K | 0.03% | 597 |
|
|
2020
Q3 | $8.44M | Buy |
52,186
+2,060
| +4% | +$326K | 0.03% | 536 |
|
|
2020
Q2 | $7.15M | Sell |
50,126
-14,296
| -22% | -$1.98M | 0.03% | 584 |
|
|
2020
Q1 | $7M | Sell |
64,422
-11,638
| -15% | -$1.68M | 0.03% | 528 |
|
|
2019
Q4 | $11.1M | Buy |
76,060
+1,130
| +2% | +$163K | 0.04% | 474 |
|
|
2019
Q3 | $10.8M | Buy |
74,930
+745
| +1% | +$109K | 0.04% | 446 |
|
|
2019
Q2 | $11M | Buy |
74,185
+3,168
| +4% | +$442K | 0.05% | 439 |
|
|
2019
Q1 | $9.33M | Buy |
71,017
+14,203
| +25% | +$1.75M | 0.04% | 484 |
|
|
2018
Q4 | $6.17M | Sell |
56,814
-12,779
| -18% | -$1.71M | 0.03% | 564 |
|
|
2018
Q3 | $10.4M | Sell |
69,593
-554
| -0.8% | -$84.3K | 0.05% | 429 |
|
|
2018
Q2 | $10.8M | Buy |
70,147
+5,947
| +9% | +$898K | 0.05% | 404 |
|
|
2018
Q1 | $8.92M | Buy |
64,200
+3,338
| +5% | +$490K | 0.04% | 460 |
|
|
2017
Q4 | $8.34M | Buy |
60,862
+1,385
| +2% | +$183K | 0.04% | 475 |
|
|
2017
Q3 | $7.71M | Sell |
59,477
-1,041
| -2% | -$139K | 0.04% | 459 |
|
|
2017
Q2 | $8.01M | Buy |
60,518
+11,423
| +23% | +$1.4M | 0.05% | 438 |
|
|
2017
Q1 | $6.05M | Buy |
49,095
+2,436
| +5% | +$288K | 0.04% | 484 |
|
|
2016
Q4 | $5.15M | Sell |
46,659
-3,934
| -8% | -$437K | 0.04% | 492 |
|
|
2016
Q3 | $5.97M | Buy |
50,593
+5,928
| +13% | +$699K | 0.04% | 481 |
|
|
2016
Q2 | $5M | Sell |
44,665
-1,712
| -4% | -$184K | 0.04% | 511 |
|
|
2016
Q1 | $4.67M | Buy |
46,377
+3,182
| +7% | +$305K | 0.04% | 504 |
|
|
2015
Q4 | $4.59M | Buy |
43,195
+4,174
| +11% | +$431K | 0.04% | 482 |
|
|
2015
Q3 | $3.64M | Buy |
39,021
+1,312
| +3% | +$136K | 0.04% | 541 |
|
|
2015
Q2 | $3.93M | Buy |
37,709
+4,938
| +15% | +$514K | 0.04% | 491 |
|
|
2015
Q1 | $3.55M | Buy |
32,771
+5,110
| +18% | +$526K | 0.04% | 499 |
|
|
2014
Q4 | $2.56M | Sell |
27,661
-891
| -3% | -$78.7K | 0.03% | 567 |
|
|
2014
Q3 | $2.5M | Buy |
28,552
+1,418
| +5% | +$128K | 0.03% | 554 |
|
|
2014
Q2 | $2.39M | Sell |
27,134
-1,242
| -4% | -$108K | 0.03% | 545 |
|
|
2014
Q1 | $2.39M | Buy |
+28,376
| New | +$2.26M | 0.03% | 643 |
|
|
2013
Q4 | – | Sell |
-33,553
| Closed | -$2.86M | – | 568 |
|
|
2013
Q3 | $2.86M | Buy |
33,553
+7,278
| +28% | +$613K | 0.06% | 458 |
|
|
2013
Q2 | $2.26M | Buy |
+26,275
| New | +$2.18M | 0.05% | 452 |
|
Other funds holding LH
Aperio Group's LH Position: Q4 2020 in Review
Aperio Group reduced its Labcorp (LH) stake by 0.3% in Q4 2020, selling an estimated $27.5K and leaving 52,027 shares worth $9.1M. The position accounts for 0.03% of the portfolio, ranked #597.
Aperio Group first reported a position in LH in Q2 2013 and has held it in 30 quarters since. The position peaked at $11.1M in Q4 2019. 907 funds tracked by Wall St. Rank hold LH as of Q4 2020.
- Aperio Group held 52,027 shares of Labcorp worth $9.1M as of Q4 2020.
- Aperio Group sold 159 Labcorp shares in Q4 2020, an estimated $27.5K.
- Labcorp made up 0.03% of Aperio Group's portfolio in Q4 2020, its #597 holding.
- Aperio Group first reported a position in Labcorp in Q2 2013 and has held it in 30 quarters since.
- Aperio Group's Labcorp position peaked at $11.1M in Q4 2019.
- 907 funds tracked by Wall St. Rank held Labcorp as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.